Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07286370RecruitingPhase 2
Vaccine study for typhoid and salmonella in infants
This study tests a new vaccine that could protect infants against typhoid fever and a serious type of salmonella. If your baby is healthy and within the age range, they may be eligible to participate.
BanjulAges 1 month–6 months - NCT07286734Recruiting
Ultrasound study of radial nerve in arm fracture with nerve injury
This study uses ultrasound and nerve tests to examine the radial nerve in people who have a broken upper arm bone (humeral shaft fracture) and also have radial nerve palsy (weakness or paralysis on the back of the hand/forearm). The goal is to better understand how the nerve is affected by the fracture.
Istanbul, KarsAges 18 years+ - NCT07286929Recruiting
Study on vision and space problems in people with parietal lobe glioma
This study looks at how vision and spatial awareness problems change over time in people with a glioma in the parietal lobe (a part of the brain). It may help doctors better understand and support these patients.
MilanAges 18 years+ - NCT07287007Recruiting
Testing a new leg compression device for blood flow
This study tests a new leg compression device called VenAir to see how well it helps blood flow. It is for healthy adults who do not have any heart or circulation problems, and who have not had blood clots or strokes in the past.
New Taipei CityAges 20–64 - NCT07287033RecruitingPhase 1
Safety study of MY006 in healthy people and people with peanut allergy
This early-phase study tests a new investigational medication (MY006) to see if it is safe and how the body processes it. It is given to both healthy volunteers and people with peanut allergy. The goal is to gather safety information before larger trials.
Colorado Springs, ColoradoAges 12–55 - NCT07287124Recruiting
New fully implantable cochlear implant for severe hearing loss
This study tests a new type of cochlear implant that is completely placed under the skin, with no external parts. It is for adults with severe hearing loss who still struggle to hear even with hearing aids.
Englewood, ColoradoAges 18 years+ - NCT07287176Recruiting
Treating benign thyroid nodules with a new device
This trial tests a new device that uses nanosecond electrical pulses to treat benign thyroid nodules. It may be an option if you have a benign nodule causing symptoms like discomfort or anxiety, and you're looking for a non-surgical treatment.
Sarasota, FloridaAges 22–80 - NCT07287241Recruiting
Heart health study for people with osteogenesis imperfecta
This study looks at heart structure and function in children and adults with osteogenesis imperfecta (OI), a condition that affects bones. Researchers want to understand how OI may impact the heart.
Bologna, Emilia-RomagnaAges 5–80 - NCT07287644RecruitingPhase 2/Phase 3
Study of BFB759 for moderate to severe hidradenitis suppurativa
This trial tests a new medication, BFB759, to see if it can help people with moderate to severe hidradenitis suppurativa (a skin condition that causes painful bumps and abscesses) when antibiotics haven't worked well enough. It is designed for adults whose symptoms are not well controlled with current treatments.
Phoenix, ArizonaAges 18–75 - NCT07287709Recruiting
Laser vs. standard treatment for painful adult molars
This study tests if using a laser is better than the usual method for treating painful, inflamed teeth that still have a live nerve. The goal is to save the tooth and reduce pain without removing the nerve entirely.
AlexandriaAges 16–50 - NCT07287774Recruiting
Testing a new noise-reduction feature for hearing aids
This trial is testing a new computer program that helps hearing aids reduce background noise. It might make it easier for people with mild to moderate hearing loss to hear in noisy places.
West Lafayette, IndianaAges 18 years+ - NCT07290179Recruiting
Can a smartwatch detect when kids eat?
This study tests if a smartwatch can automatically sense when children are eating. You and your child will wear the watch for three days to see if it works in real life.
Baton Rouge, LouisianaAges 8–12 - NCT07290244RecruitingPhase 1
Testing ER-100 safety for glaucoma or NAION patients
This trial tests whether a new drug, ER-100, is safe for people with glaucoma or a sudden optic nerve injury called NAION. It aims to see if the drug can be given without serious side effects.
Glendale, CaliforniaAges 40–85 - NCT07290790Recruiting
Trimline Aligner Accuracy Study
This trial tests SureSmile clear aligners to see how accurately they fix common bite problems like crowding, spacing, and overbite. You may be able to join if you need mild to moderate orthodontic treatment.
Fresno, CaliforniaAges 18 years+ - NCT07291076RecruitingPhase 1/Phase 2
Study of Pumitamig with Ipilimumab for first-line advanced liver cancer
This trial tests a new drug called pumitamig, either alone or with another drug (ipilimumab), for people with advanced liver cancer that hasn't been treated yet. The goal is to see if these drugs can help shrink or control the cancer.
Duarte, CaliforniaAges 18 years+ - NCT07291973Recruiting
Microwave ablation for small lung tumors
This study tests a new microwave device that uses heat to destroy small lung tumors. It may be an option if your nodule is 20 mm or smaller and cannot be removed with surgery.
ParisAges 18 years+ - NCT07292714RecruitingPhase 2
Testing 9MW1911 for people with moderate to severe COPD
This trial tests a new medication called 9MW1911 to see if it can help people with moderate to severe COPD who have had recent flare-ups. It is for current or former smokers ages 40 to 75 who are already on standard COPD treatments.
Chizhou, AnhuiAges 40–75 - NCT07292987Recruiting
Support program for people newly diagnosed with retinitis pigmentosa
This study is testing a new way to support people who have just been told they have retinitis pigmentosa (RP) at the Quinze-Vingts hospital in Paris. It aims to help you understand your diagnosis and get the care you need.
Paris, Île-de-France RegionAges 18–65 - NCT07294508RecruitingPhase 2/Phase 3
Testing a new drug combo for HER2-positive advanced breast cancer
This trial tests two study drugs, HLX22 and HLX87, together for people with HER2-positive breast cancer that has spread or come back. It may be an option if you haven't yet had chemotherapy or HER2-targeted therapy for advanced disease.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07294625RecruitingEarly Phase 1
Gene therapy for relapsed/refractory multiple myeloma
This trial tests a new gene therapy, LVIVO-TaVec200, for people with multiple myeloma that has returned or not responded to other treatments. The goal is to see if it can help control the cancer.
Zhengzhou, HenanAges 18 years+ - NCT07294976Recruiting
Testing maximum gain in bone-anchored hearing devices
This trial tests the maximum sound gain you can get from your bone-anchored hearing device. If you already use an Oticon Medical compatible system and have mixed hearing loss, this study will check how well your device performs.
GothenburgAges 18 years+ - NCT07295457Recruiting
Exercise to prevent pain from hormone therapy in breast cancer
This trial tests whether starting a gentle exercise program early can help prevent or reduce joint and muscle pain caused by aromatase inhibitors (a common breast cancer medicine). It is for women with hormone-sensitive breast cancer who are not yet experiencing severe pain from their treatment.
LyonAges 18–75 - NCT07295717RecruitingPhase 1
ALN-4285 safety study in healthy adults
This study tests a new medicine called ALN-4285 in healthy adults to see how safe it is and how the body processes it. It may help find a new treatment for certain conditions.
LondonAges 18–65 - NCT07296458RecruitingPhase 3
Fenofibrate for first-line treatment of primary biliary cholangitis
This study tests whether fenofibrate, a medicine that lowers fats in the blood, can help people with primary biliary cholangitis (a chronic liver disease) who haven't had treatment before. It aims to see if it is safe and effective as a first treatment option.
Xi'an, ShaanxiAges 18–75
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.